|4Feb 19, 3:47 PM ET

PRAXAIR INC 4

4 · PRAXAIR INC · Filed Feb 19, 2014

Insider Transaction Report

Form 4
Period: 2014-02-18
Breedlove James T
Senior VP, Gen. Counsel & Sec.
Transactions
  • Sale

    Common Stock

    2014-02-18$129.83/sh40,000$5,193,20033,614 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-02-1840,0004,120 total
    Exercise: $60.92From: 2010-02-24Exp: 2019-02-24Common Stock (40,000 underlying)
  • Exercise/Conversion

    Common Stock

    2014-02-18$60.92/sh+40,000$2,436,80073,614 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    5,237.424
  • Stock Option (right to buy)

    Exercise: $83.89From: 2009-02-26Exp: 2018-02-26Common Stock (39,300 underlying)
    39,300
  • Stock Option (right to buy)

    Exercise: $76.16From: 2011-02-23Exp: 2020-02-23Common Stock (34,960 underlying)
    34,960
  • Stock Option (right to buy)

    Exercise: $97.84From: 2012-02-22Exp: 2021-02-22Common Stock (37,930 underlying)
    37,930
  • Stock Option (right to buy)

    Exercise: $109.68From: 2013-02-28Exp: 2022-02-28Common Stock (36,095 underlying)
    36,095
  • Stock Option (right to buy)

    Exercise: $110.58From: 2014-02-26Exp: 2023-02-26Common Stock (29,755 underlying)
    29,755
  • Deferred Stock

    Exercise: $0.00Common Stock (1,259.54 underlying)
    1,259.54
Footnotes (7)
  • [F1]The $129.83 price reported is the weighted average sale price. The sale prices ranged from $129.47 to $130.178 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
  • [F2]This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
  • [F3]This option vests over three years in three consecutive equal annual installments beginning on February 22, 2012.
  • [F4]This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.
  • [F5]This option vests over three years in three consecutive equal annual installments beginning on February 26, 2014.
  • [F6]Conversion to Praxair Common Stock is on a 1-for-1 basis.
  • [F7]Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferral Program") and are to be settled in Praxair Common Stock.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT